2648207
SCDFP · Clinical drug packinfluenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza A virus A/Kansas/14/2017 (H3N2) antigen / influenza B virus B/Maryland/15/2016 antigen / influenza B virus B/Phuket/3073/2013 antigen Injection
Concept
RxCUI2648207
Nameinfluenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza A virus A/Kansas/14/2017 (H3N2) antigen / influenza B virus B/Maryland/15/2016 antigen / influenza B virus B/Phuket/3073/2013 antigen Injection
Term typeSCDFP · Clinical drug pack
LanguageENG
Cross-maps
UMLS CUIC5836893
Synonyms
No additional synonyms recorded.
Related concepts
26478956-O-palmitoylascorbic acid / alpha-tocopherol acetate / levocarnitine / ubidecarenone Oral Capsule
2646107Bordetella pertussis filamentous hemagglutinin vaccine, inactivated / Bordetella pertussis fimbriae 2/3 vaccine, inactivated / Bordetella pertussis pertactin vaccine, inactivated / Bordetella pertussis toxoid vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injection
2649329Bordetella pertussis filamentous hemagglutinin vaccine, inactivated / Bordetella pertussis fimbriae 2/3 vaccine, inactivated / Bordetella pertussis pertactin vaccine, inactivated / Bordetella pertussis toxoid vaccine, inactivated / diphtheria toxoid vaccine, inactivated / Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine / hepatitis B surface antigen vaccine / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Prefilled Syringe
2646210Bordetella pertussis filamentous hemagglutinin vaccine, inactivated / Bordetella pertussis fimbriae 2/3 vaccine, inactivated / Bordetella pertussis pertactin vaccine, inactivated / Bordetella pertussis toxoid vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Injection
2649193Bordetella pertussis filamentous hemagglutinin vaccine, inactivated / Bordetella pertussis fimbriae 2/3 vaccine, inactivated / Bordetella pertussis pertactin vaccine, inactivated / Bordetella pertussis toxoid vaccine, inactivated / diphtheria toxoid vaccine, inactivated / poliovirus vaccine inactivated, type 1 (Mahoney) / poliovirus vaccine inactivated, type 2 (MEF-1) / poliovirus vaccine inactivated, type 3 (Saukett) / tetanus toxoid vaccine, inactivated Prefilled Syringe
# same page, as API
GET autoicdapi.com/api/v1/reference/rxnorm/2648207
GET autoicdapi.com/api/v1/translate?code=2648207&from=rxnorm&to=umls
Common questions
What is the RxNorm code for influenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza A virus A/Kansas/14/2017 (H3N2) antigen / influenza B virus B/Maryland/15/2016 antigen / influenza B virus B/Phuket/3073/2013 antigen Injection?
influenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza A virus A/Kansas/14/2017 (H3N2) antigen / influenza B virus B/Maryland/15/2016 antigen / influenza B virus B/Phuket/3073/2013 antigen Injection is coded as 2648207 in RxNorm.
What is RxNorm code 2648207?
2648207 is the RxNorm identifier for influenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza A virus A/Kansas/14/2017 (H3N2) antigen / influenza B virus B/Maryland/15/2016 antigen / influenza B virus B/Phuket/3073/2013 antigen Injection. It is included in the current monthly NLM RxNorm release.
What term type is RxCUI 2648207?
2648207 is a SCDFP (Clinical drug pack) in RxNorm.
What is the UMLS mapping for 2648207?
2648207 maps to UMLS C5836893.
RxNorm, plainly answered
What is RxNorm?
RxNorm is the NLM's normalized naming system for clinical drugs and dose forms. It collapses brand variants, packaging differences, and source-vocabulary noise into a single, stable identifier (RxCUI) per concept, with explicit links to ingredients, brands, and clinical drug forms.
What are RxCUIs?
An RxCUI is the persistent ID for a single RxNorm concept. The same RxCUI keeps pointing at the same drug concept release after release, even when names or sources change. That stability is what makes RxNorm useful for medication reconciliation and analytics.
How does RxNorm relate to NDC codes?
NDC codes describe a specific package SKU at a specific manufacturer. RxNorm describes the clinically relevant drug. One RxCUI can map to dozens of NDCs (different manufacturers, different package sizes), and we list those NDC mappings on each concept page.
How does RxNorm cross-map to other standards?
RxNorm concepts carry direct links to UMLS CUIs and SNOMED CT product codes when available. Through the UMLS bridge they can also reach ICD-10 codes (for instance, for indication-based coding) and LOINC observations. Our API exposes all of this on the cross_references field.
Is the API free to use?
Browsing concepts is free. Programmatic access at /api/v1/reference/rxnorm/* requires an API key. RxNorm itself is in the public domain, so there is no upstream license fee, but our bandwidth and uptime are not.
How fresh is the RxNorm data?
RxNorm releases monthly. We rebuild within a few business days of each release, and the concept-id history is preserved so previous lookups continue to resolve.